Position in NVO
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,223,237
+$327,309 QoQ
Shares Held
25,516
+4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#478
of 1,348 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL ADVISORS INC/OK holds $173,896,300 across 10 Drug Manufacturers - General names. NVO ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
447,129 | $112,515,541 | |
| 2 | PFE |
Pfizer Inc
|
1,770,761 | $42,639,924 | |
| 3 | LLY |
ELI LILLY & Co
|
6,287 | $7,540,817 | |
| 4 | JNJ |
Johnson & Johnson
|
22,507 | $5,716,102 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,641 | $1,419,814 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,821 | $1,261,998 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
25,516 | $1,223,237 | |
| 8 | AMGN |
Amgen Inc
|
2,255 | $816,580 |
All Filings in NVO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,223,237 | 25,516 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $895,928 | 24,379 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,033,423 | 20,311 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,149,974 | 20,724 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,550,741 | 22,468 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,556,150 | 22,410 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,607,041 | 65,183 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,639,827 | 66,892 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $8,641,771 | 88,446 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $9,235,733 | 99,938 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $571,457 | 5,524 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $8,066,014 | 88,696 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $369,619 | 2,284 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $358,542 | 2,253 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $302,620 | 2,236 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $222,772 | 2,236 | Shares | Sole | 2022-10-17 | |
| No filing history on record for this holder in this stock. | ||||||